Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov;30(12):7910-7911.
doi: 10.1245/s10434-023-14301-w. Epub 2023 Sep 14.

ASO Author Reflections: Cancer-Specific Mortality of Non-Muscle-Invasive Bladder Cancer

Aleksander Ślusarczyk  1
Affiliations

ASO Author Reflections: Cancer-Specific Mortality of Non-Muscle-Invasive Bladder Cancer

Aleksander Ślusarczyk. Ann Surg Oncol. 2023 Nov.
No abstract available

PubMed Disclaimer

Conflict of interest statement

No conflict of interest to declare.

References

    1. Cambier S, Sylvester RJ, Collette L, Gontero P, Brausi MA, van Andel G, et al. EORTC nomograms and risk groups for predicting recurrence, progression, and disease-specific and overall survival in non-muscle-invasive stage Ta-T1 urothelial bladder cancer patients treated with 1–3 years of maintenance bacillus Calmette-Guérin. Eur Urol. 2016;69(1):60–69. doi: 10.1016/j.eururo.2015.06.045. - DOI - PubMed
    1. van den Bosch S, Alfred WJ. Long-term cancer-specific survival in patients with high-risk, non-muscle-invasive bladder cancer and tumour progression: a systematic review. Eur Urol. 2011;60(3):493–500. doi: 10.1016/j.eururo.2011.05.045. - DOI - PubMed
    1. Sylvester RJ, Rodríguez O, Hernández V, Turturica D, Bauerová L, Bruins HM, et al. European Association of Urology (EAU) prognostic factor risk groups for non-muscle-invasive bladder cancer (NMIBC) incorporating the WHO 2004/2016 and WHO 1973 classification systems for grade: an update from the EAU NMIBC guidelines panel. Eur Urol. 2021;79(4):480–488. doi: 10.1016/j.eururo.2020.12.033. - DOI - PubMed
    1. Ślusarczyk A, Zapała P, Zapała Ł, Piecha T, Radziszewski P. Prediction of BCG responses in non-muscle-invasive bladder cancer in the era of novel immunotherapeutics. Int Urol Nephrol. 2019;51(7):1089–1099. doi: 10.1007/s11255-019-02183-5. - DOI - PubMed
    1. Ślusarczyk A, Zapała P, Zapała Ł, Borkowski T, Radziszewski P. Cancer-specific survival of patients with non-muscle-invasive bladder cancer: a population-based analysis. Ann Surg Oncol. 2023 doi: 10.1245/s10434-023-14051-9. - DOI - PMC - PubMed

LinkOut - more resources